Access to chimeric antigen T-cell receptor (CAR-T) therapy for patients with Non-Hodgkin Lymphoma (NHL) in Oregon
Somya Khare(Oregon Health & Science University), Eneida R. Nemecek(Oregon Health & Science University), Jessica Leonard(Oregon Health & Science University), Kevin M. Christmas(Oregon Health & Science University), Staci Williamson(Oregon Health & Science University), Levanto Schachter(Oregon Health & Science University), Richard T. Maziarz(Oregon Health & Science University), Brittany O'Barr(Oregon Health & Science University), Peter Ferreira-Gandolfo(Oregon Health & Science University), Andy Chen(Stanford University), Denise E. Lackey(Oregon Health & Science University), Brandon Hayes‐Lattin(Oregon Health & Science University)
Cited by 0
Related Papers
Tisagenlecleucel in Children and Young Adults with B-Cell Lymphoblastic Leukemia
|New England Journal of Medicine|2018|5.7k
Lenalidomide after Stem-Cell Transplantation for Multiple Myeloma
|New England Journal of Medicine|2012|1.2k
Myeloablative Versus Reduced-Intensity Hematopoietic Cell Transplantation for Acute Myeloid Leukemia and Myelodysplastic Syndromes
|Journal of Clinical Oncology|2017|664
Genetic mechanisms of target antigen loss in CAR19 therapy of acute lymphoblastic leukemia
|Nature Medicine|2018|577